Clinical Trial Update: PENTA Fosamprenavir Study

View source ↗

Summary

The PENTA Fosamprenavir Study (NCT01077635) sponsored by ViiV Healthcare has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fosamprenavir (fosamprenavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Status: COMPLETED